LV10387B - Process for producing of drugs and application thereof on medicinal purpose - Google Patents

Process for producing of drugs and application thereof on medicinal purpose Download PDF

Info

Publication number
LV10387B
LV10387B LVP-93-303A LV930303A LV10387B LV 10387 B LV10387 B LV 10387B LV 930303 A LV930303 A LV 930303A LV 10387 B LV10387 B LV 10387B
Authority
LV
Latvia
Prior art keywords
alkyl
hydrogen
der
formula
und
Prior art date
Application number
LVP-93-303A
Other languages
English (en)
Latvian (lv)
Other versions
LV10387A (lv
Inventor
Baader Ekkehard
Burghard Harald
Genzler-Pukall Volkmar
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of LV10387A publication Critical patent/LV10387A/xx
Publication of LV10387B publication Critical patent/LV10387B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/56—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having carbon atoms of carboxamide groups bound to carbon atoms of carboxyl groups, e.g. oxamides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
LVP-93-303A 1990-05-12 1993-05-07 Process for producing of drugs and application thereof on medicinal purpose LV10387B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4015255A DE4015255A1 (de) 1990-05-12 1990-05-12 Oxalyl-aminosaeurederivate, verfahren zu ihrer herstellung und ihrer verwendung als arzneimittel zur inhibierung der prolyl-hydroxylase

Publications (2)

Publication Number Publication Date
LV10387A LV10387A (lv) 1995-02-20
LV10387B true LV10387B (en) 1996-02-20

Family

ID=6406245

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-303A LV10387B (en) 1990-05-12 1993-05-07 Process for producing of drugs and application thereof on medicinal purpose

Country Status (28)

Country Link
US (1) US5204338A (fr)
EP (1) EP0457163B1 (fr)
JP (1) JP2504874B2 (fr)
KR (1) KR910019612A (fr)
CN (1) CN1032253C (fr)
AT (1) ATE108177T1 (fr)
AU (1) AU641760B2 (fr)
BR (1) BR9101927A (fr)
CA (1) CA2042282A1 (fr)
CZ (1) CZ279939B6 (fr)
DE (2) DE4015255A1 (fr)
DK (1) DK0457163T3 (fr)
EG (1) EG19762A (fr)
ES (1) ES2057655T3 (fr)
HR (1) HRP940695B1 (fr)
HU (1) HU217974B (fr)
IE (1) IE65298B1 (fr)
IL (1) IL98109A (fr)
LT (1) LT3953B (fr)
LV (1) LV10387B (fr)
MA (1) MA22152A1 (fr)
MX (1) MX25723A (fr)
MY (1) MY108608A (fr)
NZ (1) NZ238112A (fr)
PT (1) PT97642B (fr)
RU (1) RU2025123C1 (fr)
TW (1) TW225988B (fr)
ZA (1) ZA913538B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192773A (en) * 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds
ES2137186T3 (es) * 1991-05-09 1999-12-16 Vertex Pharma Nuevos compuestos inmunosupresores.
US5620971A (en) * 1991-05-09 1997-04-15 Vertex Pharmaceuticals Incorporated Biologically active acylated amino acid derivatives
US5723459A (en) * 1991-05-09 1998-03-03 Vertex Pharmaceuticals Incorporated Biologically active acylated amino acid derivatives
ES2101420T3 (es) * 1993-11-02 1997-07-01 Hoechst Ag Esteres-amidas de acidos carboxilicos heterociclicos sustituidos, su preparacion y su utilizacion como medicamentos.
EP0650961B1 (fr) 1993-11-02 1997-03-05 Hoechst Aktiengesellschaft Amides d'acide carboxylique hétérocycliques substitués, leur preparation et leur utilisation comme médicaments
NZ270267A (en) * 1993-12-30 1997-03-24 Hoechst Ag 3-hydroxypyridin-2yl (and -quinolin-2-yl) carboxamide derivatives and pharmaceutical compositions
US5543423A (en) * 1994-11-16 1996-08-06 Vertex Pharmaceuticals, Incorporated Amino acid derivatives with improved multi-drug resistance activity
US6046219A (en) * 1995-01-20 2000-04-04 Cornell Research Foundation, Inc. Method for the treatment of conditions mediated by collagen formation together with cell proliferation by application of inhibitors of protein hydroxylation
US5789426A (en) * 1995-01-20 1998-08-04 Cornell Research Foundation, Inc. Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
US7056935B2 (en) 1995-06-07 2006-06-06 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
IL135495A (en) * 1995-09-28 2002-12-01 Hoechst Ag Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid
US5801197A (en) * 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5717092A (en) * 1996-03-29 1998-02-10 Vertex Pharmaceuticals Inc. Compounds with improved multi-drug resistance activity
US5786378A (en) * 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
US5801187A (en) 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
US6218424B1 (en) 1996-09-25 2001-04-17 Gpi Nil Holdings, Inc. Heterocyclic ketone and thioester compounds and uses
DE19650215A1 (de) * 1996-12-04 1998-06-10 Hoechst Ag 3-Hydroxypyridin-2-carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel
US6274602B1 (en) 1998-06-03 2001-08-14 Gpi Nil Holdings, Inc. Heterocyclic thioester and ketone hair growth compositions and uses
US20010049381A1 (en) 1997-06-04 2001-12-06 Gpl Nil Holdings, Inc., Pyrrolidine derivative hair growth compositions and uses
US6271244B1 (en) 1998-06-03 2001-08-07 Gpi Nil Holdings, Inc. N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses
US6187784B1 (en) 1998-06-03 2001-02-13 Gpi Nil Holdings, Inc. Pipecolic acid derivative hair growth compositions and uses
US6187796B1 (en) 1998-06-03 2001-02-13 Gpi Nil Holdings, Inc. Sulfone hair growth compositions and uses
US5945441A (en) * 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
DE19746287A1 (de) * 1997-10-20 1999-04-22 Hoechst Marion Roussel De Gmbh Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
US6172087B1 (en) 1998-06-03 2001-01-09 Gpi Nil Holding, Inc. N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
EP1085853A1 (fr) 1998-06-03 2001-03-28 GPI NIL Holdings, Inc. Compositions pour la croissance des cheveux a base d'amides et d'esters heterocycliques et utilisation de ces compositions
US6429215B1 (en) 1998-06-03 2002-08-06 Gpi Nil Holdings, Inc. N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
US6333340B1 (en) 1998-08-14 2001-12-25 Gpi Nil Holdings, Inc. Small molecule sulfonamides for vision and memory disorders
US7338976B1 (en) 1998-08-14 2008-03-04 Gpi Nil Holdings, Inc. Heterocyclic esters or amides for vision and memory disorders
US6335348B1 (en) 1998-08-14 2002-01-01 Gpi Nil Holdings, Inc. Nitrogen-containing linear and azepinyl/ compositions and uses for vision and memory disorders
US6506788B1 (en) 1998-08-14 2003-01-14 Gpi Nil Holdings, Inc. N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders
US6384056B1 (en) 1998-08-14 2002-05-07 Gpi Nil Holdings, Inc. Heterocyclic thioesters or ketones for vision and memory disorders
US6462072B1 (en) 1998-09-21 2002-10-08 Gpi Nil Holdings, Inc. Cyclic ester or amide derivatives
CN102552263A (zh) * 2001-12-06 2012-07-11 法布罗根股份有限公司 提高内源性红细胞生成素(epo)的方法
RU2214596C1 (ru) * 2002-05-21 2003-10-20 Подковкин Владимир Георгиевич Способ оценки метаболизма коллагена
WO2006134963A1 (fr) * 2005-06-15 2006-12-21 Nippon Zoki Pharmaceutical Co., Ltd. Agent pour des maladies fibreuses comprenant un dérivé de l'acide oxalurique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1195854A (en) * 1966-08-08 1970-06-24 Ajinomoto Kk Oxazole Derivatives and process of producing the same
DE1645987A1 (de) * 1966-08-08 1971-01-21 Ajinomoto Kk Oxalzolderivate und Verfahren zu deren Herstellung
US3646061A (en) * 1968-06-10 1972-02-29 Ajinomoto Kk Method of preparing n-alkoxalyl and n-formyl derivatives of alpha-amino acid esters

Also Published As

Publication number Publication date
MA22152A1 (fr) 1991-12-31
DE4015255A1 (de) 1991-11-14
ES2057655T3 (es) 1994-10-16
DK0457163T3 (da) 1994-10-17
JP2504874B2 (ja) 1996-06-05
IE911608A1 (en) 1991-11-20
HRP940695A2 (en) 1997-02-28
PT97642A (pt) 1992-02-28
IE65298B1 (en) 1995-10-18
LT3953B (en) 1996-05-27
HUT57581A (en) 1991-12-30
IL98109A0 (en) 1992-06-21
PT97642B (pt) 1998-08-31
RU2025123C1 (ru) 1994-12-30
MY108608A (en) 1996-10-31
CA2042282A1 (fr) 1991-11-13
ATE108177T1 (de) 1994-07-15
ZA913538B (en) 1992-02-26
KR910019612A (ko) 1991-12-19
JPH04226913A (ja) 1992-08-17
BR9101927A (pt) 1991-12-17
TW225988B (fr) 1994-07-01
EG19762A (en) 1996-01-31
DE59102102D1 (de) 1994-08-11
US5204338A (en) 1993-04-20
AU7622191A (en) 1991-11-14
CZ279939B6 (cs) 1995-09-13
CN1032253C (zh) 1996-07-10
HU157291D0 (en) 1991-11-28
EP0457163B1 (fr) 1994-07-06
LTIP1460A (en) 1995-05-25
LV10387A (lv) 1995-02-20
MX25723A (es) 1993-04-01
HU217974B (hu) 2000-05-28
CN1056683A (zh) 1991-12-04
EP0457163A1 (fr) 1991-11-21
NZ238112A (en) 1993-12-23
IL98109A (en) 1995-07-31
HRP940695B1 (en) 1999-04-30
AU641760B2 (en) 1993-09-30

Similar Documents

Publication Publication Date Title
LV10387B (en) Process for producing of drugs and application thereof on medicinal purpose
DE69316367T2 (de) Natürliche aminosäurederivate als metalloproteinase-inhibitoren
DE69509401T2 (de) Peptidische verbindungen und deren therapeutische verwendung als metalloproteinase-inhibitoren
DE69213256T2 (de) Organische salze von n, n'-diacetylcystin
DE69325178T2 (de) Durch peptidylketon aktivierte inhibitoren, die natürliche und nicht-natürliche peptidsequenzen enthalten
US4137420A (en) Cysteine derivatives
DE3883495T2 (de) Enantiomere Derivate von Aminosäure, Verfahren zu deren Herstellung und deren therapeutische Verwendung.
DE69122961T2 (de) Pharmakologische verwendung bestimmter cystinderivate
EP0119161B1 (fr) Dérivés de benzazocinone et benzazoninon, leur procédé de préparation, préparations pharmaceutiques contenant ces composés, et leur application thérapeutique
DE69013511T2 (de) Aminosäurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
CH685436A5 (de) Brenzkatechin-Derivate und ihre Verwendung als Arzneistoffe.
DE3872937T2 (de) Benzoylaminophenoxybuttersaeure-derivate.
DE3889726T2 (de) Synthetische inhibitoren von säugetier-collagenase.
DE3443231A1 (de) Polysubstituierte naphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung auf dem pharmazeutischen und kosmetischen gebiet
DE69209442T2 (de) Dipeptidderivate und sie enthaltende prophylaktische und therapeutische Mittel für Knochenkrankheiten
DE69624477T2 (de) Peptide, die metallproteinasen und die tnf-freisetzung hemmen, und ihre therapeutische verwendung
DE3851262T2 (de) Benzoylaminophenoxybuttersäure-Derivate.
CA1294971C (fr) Derives benzofuranniques, leurs procedes de preparation et compositions medicamenteuse et cosmetique les contenant
US4839387A (en) Derivative of thiazolidine-4-carboxylic acid, its preparation and pharmaceutical compositions containing it
JP2957123B2 (ja) アミド由来のビアロマティック化合物、これを含有する製薬及び化粧品組成物及びその使用
FR2713637A1 (fr) Nouveaux composés bi-aromatiques dérivés d'amide, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
CA1340005C (fr) Composition pharmceutique pour le traitment du psoriasis
DE3138092C2 (de) Verwendung von 3-Amino-2-hydroxy-4-phenylbuttersäure und einigen ihrer verwandten Verbindungen
DE2727047A1 (de) Indol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
PT98121B (pt) Processo para a preparacao de novos 3,3'-ditio-bis (acidos propionicos) e seus esteres e de composicoes farmaceuticas que os contem